RESEARCH LINES
- Generation of therapeutic antibodies sensible to stimulus
- Directed evolution of peptides and proteins using phage display
- Development of antibody-drug conjugates for the treatment of brain tumours
MEMBER OF:
School of Engineering
Materials Engineering
Its activities focus on three main areas: the development of new functional materials, surface engineering and biomaterials.
School of Engineering
Chemical & Synthetic Biology for Biotherapies
This group combines chemistry and synthetic biology to develop precision bio-nano-therapeutics based on smart proteins and to generate molecular systems that enable transport of therapeutics to the brain.
LATEST PROJECTS
ADC2GBM (Development of brain-permeable masked nanobody-drug conjugates to eliminate glioma stem cells)
Innovative formulation to treat glioma using brain-permeable masked nanobody-drug conjugates.
Funding Agency:
Research Group Link:
Materials Engineering (GEMAT)
Chemical & Synthetic Biology for Biotherapies (ChemSynBio)
LINKED NEWS
Interview
Interview with Montse Escobar, IQS Predoctoral Researcher
01/12/2023
Montse Escobar has earned an INPhINIT grant awarded by the "la Caixa" Foundation to carry out her doctoral thesis within the Bioengineering Department at IQS. This represents the first INPhINIT grant awarded to the school.
READ FULL NEW
Interview
Producing masked antibodies through targeted evolution
01/09/2022
“In the ADC2GBM project, we're combining our experience in targeted evolution and antibody engineering to develop activatable antibody-drug conjugates for the treatment of glioblastoma multiforme”
READ FULL NEW
7 Questions for...
Cristina Díaz
12/05/2022
Interview to Dr Cristina Díaz, researcher with the GEMAT group at the IQS School of Engineering.
READ FULL NEW
